Results of the TIMI IIIB Trial. Thrombolysis in Myocardial Ischemia. Circulation. 1994;89:1545 56. 94. PRISM-PLUS Study Investigators. Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myo- cardial infarction. Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) Study Investigators. N Engl J Med. 1998;338:1488 97. 95. Chang WC, Boersma E, Granger CB, et al. Dynamic prognostication in non-ST-elevation acute coronary syndromes: insights from GUSTO-IIb and PURSUIT. Am Heart J. 2004;148:62 71. 96. Ronner E, Boersma E, Laarman GJ, et al. Early angioplasty in acute coronary syndromes without persistent ST-segment elevation improves outcome but increases the need for six-month repeat revascularization: an analysis of the PURSUIT Trial. Platelet glycoprotein IIB/IIIA in Unstable angina: Receptor Suppression Using Integrilin Therapy. J Am Coll Cardiol. 2002;39:1924 9. 97. Theroux P, Alexander JJ, Pharand C, et al. Glycoprotein IIb/IIIa recep- tor blockade improves outcomes in diabetic patients presenting with unstable angina/non-ST-elevation myocardial infarction: results from the Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) study. Circulation. 2000;102:2466 72. 98. Zhao XQ, Theroux P, Snapinn SM, et al. Intracoronary thrombus and platelet glycoprotein IIb/IIIa receptor blockade with tirofiban in unstable angina or non-Q-wave myocardial infarction. Angiographic results from the PRISM-PLUS trial (Platelet receptor inhibition for ischemic syn- drome management in patients limited by unstable signs and symptoms). PRISM-PLUS Investigators. Circulation. 1999;100:1609 15. 99. BraunwaldE.Unstableangina.Aclassification.Circulation.1989;80:410 4. 100. Chaitman BR, Bourassa MG, Davis K, et al Angiographic prevalence of high-risk coronary artery disease in patient subsets (CASS). Circulation. 1981;64:360 7. 101. Pryor DB, Harrell FE Jr., Lee KL, et al. Estimating the likelihood of significant coronary artery disease. Am J Med. 1983;75:771 80. 102. Pryor DB, Shaw L, McCants CB, et al. 